| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Published online before print May 17, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Biochemisches Institut, Christian-Albrechts-Universität zu Kiel, Germany;
NovImmune SA, Geneva, Switzerland; and
Department of Medical Biochemistry and Immunology, The School of Medicine Cardiff University, Wales, United Kingdom
1Correspondence: Institut für Biochemie, Christian-Albrechts-Universität zu Kiel, Olshausenstr. 40, D-24098 Kiel, Germany. E-mail: rosejohn{at}biochem.uni-kiel.de
ABSTRACT
Cytokine receptors, which exist in membrane-bound and soluble forms, bind their ligands with comparable affinity. Although most soluble receptors are antagonists and compete with their membrane-associated counterparts for the ligands, certain soluble receptors are agonists. In these cases, complexes of ligand and soluble receptor bind on target cells to second receptor subunits and initiate intracellular signaling. The soluble receptors of the interleukin (IL)-6 family of cytokines (sIL-6R, sIL-11R, soluble ciliary neurotrophic factor receptor) are agonists capable of transmitting signals through interaction with the universal signal-transducing receptor for all IL-6 family cytokines, gp130. In vivo, the IL-6/sIL-6R complex stimulates several types of cells, which are unresponsive to IL-6 alone, as they do not express the membrane IL-6R. We have named this process trans-signaling. The generation of soluble cytokine receptors occurs via two distinct mechanisms—limited proteolysis and translation—from differentially spliced mRNA. We have demonstrated that a soluble form of the IL-6 family signaling receptor subunit gp130, which is generated by differential splicing, is the natural inhibitor of IL-6 trans-signaling responses. We have shown that in many chronic inflammatory diseases, including chronic inflammatory bowel disease, peritonitis, rheumatoid arthritis, asthma, as well as colon cancer, IL-6 trans-signaling is critically involved in the maintenance of a disease state, by promoting transition from acute to chronic inflammation. Moreover, in all these models, the course of the disease can be disrupted by specifically interfering with IL-6 trans-signaling using the soluble gp130 protein. The pathophysiological mechanisms by which the IL-6/sIL-6R complex regulates the inflammatory state are discussed.
Key Words: cytokine • cytokine receptor • gp130 • sgp130Fc fusion protein
This article has been cited by other articles:
|
|
 |
|
  N. Nishimoto, K. Terao, T. Mima, H. Nakahara, N. Takagi, and T. Kakehi Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease Blood, November 15, 2008; 112(10): 3959 - 3964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tenhumberg, G. H. Waetzig, A. Chalaris, B. Rabe, D. Seegert, J. Scheller, S. Rose-John, and J. Grotzinger Structure-guided Optimization of the Interleukin-6 Trans-signaling Antagonist sgp130 J. Biol. Chem., October 3, 2008; 283(40): 27200 - 27207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Simon, A. K. O. Denniston, P. J. Tomlins, G. R. Wallace, S. Rauz, M. Salmon, P. I. Murray, and S. J. Curnow Soluble gp130, an Antagonist of IL-6 Transsignaling, Is Elevated in Uveitis Aqueous Humor Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3988 - 3991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Velez, S. J. Fortunato, S. M. Williams, and R. Menon Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth Hum. Mol. Genet., June 1, 2008; 17(11): 1619 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Briso, O. Dienz, and M. Rincon Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells J. Immunol., June 1, 2008; 180(11): 7102 - 7106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Skogstrand, D. M. Hougaard, D. E. Schendel, N.-P. Bent, C. Svaerke, and P. Thorsen Association of Preterm Birth With Sustained Postnatal Inflammatory Response Obstet. Gynecol., May 1, 2008; 111(5): 1118 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rabe, A. Chalaris, U. May, G. H. Waetzig, D. Seegert, A. S. Williams, S. A. Jones, S. Rose-John, and J. Scheller Transgenic blockade of interleukin 6 transsignaling abrogates inflammation Blood, February 1, 2008; 111(3): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. V. Popovic, R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al. Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity J. Immunol., November 15, 2007; 179(10): 6770 - 6782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dominguez-Villar, A. Munoz-Suano, B. Anaya-Baz, S. Aguilar, J. P. Novalbos, J. A. Giron, M. Rodriguez-Iglesias, and F. Garcia-Cozar Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis J. Leukoc. Biol., November 1, 2007; 82(5): 1301 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pejcic-Karapetrovic, K. Gurnani, M. S. Russell, B. B. Finlay, S. Sad, and L. Krishnan Pregnancy Impairs the Innate Immune Resistance to Salmonella typhimurium Leading to Rapid Fatal Infection J. Immunol., November 1, 2007; 179(9): 6088 - 6096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dominitzki, M. C. Fantini, C. Neufert, A. Nikolaev, P. R. Galle, J. Scheller, G. Monteleone, S. Rose-John, M. F. Neurath, and C. Becker Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25 T Cells J. Immunol., August 15, 2007; 179(4): 2041 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells J. Biol. Chem., February 2, 2007; 282(5): 3014 - 3026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Shore Obesity and asthma: lessons from animal models J Appl Physiol, February 1, 2007; 102(2): 516 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Ammit, L. M. Moir, B. G. Oliver, J. M. Hughes, H. Alkhouri, Q. Ge, J. K. Burgess, J. L. Black, and M. Roth Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L199 - L206. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
